Syk-dependent homologous recombination activation promotes cancer resistance to DNA targeted therapy.
Syk依赖的同源重组激活促进癌症对DNA靶向治疗的耐药性
期刊:Drug Resistance Updates
影响因子:21.7
doi:10.1016/j.drup.2024.101085
Zhou Qin, Tu Xinyi, Hou Xiaonan, Yu Jia, Zhao Fei, Huang Jinzhou, Kloeber Jake, Olson Anna, Gao Ming, Luo Kuntian, Zhu Shouhai, Wu Zheming, Zhang Yong, Sun Chenyu, Zeng Xiangyu, Schoolmeester Kenneth J, Weroha John S, Hu Xiwen, Jiang Yanxia, Wang Liewei, Mutter Robert W, Lou Zhenkun
